Zydus Cadila
India  /  Published 02.02.22

ZyCoV-D arrives in India

Drug firm Zydus Cadila on Wednesday said it has commenced supplies of its Covid-19 vaccine ZyCoV-D to the central government. The company has initiated the supply as per the order placed by the gover...
By Our Bureau, PTI in New Delhi

India  /  Published 26.12.21

Modi: Jabs for 15-18 years, booster for 60 plus

India will offer Covid-19 vaccination to adolescents between 15 and 18 years and booster doses to healthcare and frontline workers, and people aged 60 or older who have co-morbidities, starting in Jan...
By G.S. Mudur in New Delhi

India  /  Published 14.11.21

ZyCov-D jab only for adults

Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults as of now under the government&...
By Our Bureau, PTI in New Delhi

India  /  Published 07.11.21

One crore ZyCoV-D doses ordered

Zydus Cadila's three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order with the Ahmedabad-...
By Payal Banerjee in New Delhi

India  /  Published 31.10.21

Zydus Cadila to reduce its Covid jab price

Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sund...
By Our Bureau, PTI in New Delhi


India  /  Published 03.10.21

ZyCov-D: Govt negotiating price

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for its three-do...
By Our Bureau, PTI in New Delhi

India  /  Published 24.09.21

Shilpa Medicare to make ZyCov-D

Drug firm Cadila Healthcare on Friday said it has entered into an agreement with Shilpa Medicare for the production of its COVID-19 vaccine, ZyCoV-D. The company has, "entered into a definitive ...
By Our Bureau, PTI in New Delhi

India  /  Published 25.08.21

Govt to plan on ZyCoV-D roadmap soon

The National Technical Advisory Group on Immunisation (NTAGI) will soon hold a meeting to devise a roadmap for introducing Zydus Cadila's Covid vaccine in the inoculation drive and prioritising be...
By Payal Banerjee

Opinion  /  Published 24.08.21

Letters to the editor: Nod to three-dose Covid vaccine for kids

Hopeful moment Sir — The Drug Controller General of India’s approval for ZyCoV-D, the three-dose DNA vaccine manufactured by Zydus Cadila, comes as a relief for parents. Children aged 12 ...
By The Telegraph

India  /  Published 22.08.21

Zydus readies for output challenge

Zydus Cadila expects to produce 30 to 40 million doses of its Covid-19 vaccine by December instead of the 50 million doses the Centre hoped to receive from the Ahmedabad-based maker of India’s f...
By G.S. Mudur in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.